UGT Investigation

  • Check with publisher
  • Published date: January 15, 2020
    • Shirley, New York, United States

Drug-drug interaction (DDI) is a major concern when multiple drugs are co-administrated and interfere the metabolism of one another. In effort to minimize DDI liability, a comprehensive understanding of drug metabolism pathway and interference potency on key enzymes is absolutely crucial. In general, enzymes participating in catalyzing chemical conversions during most drug metabolizing process can be characterized as Phase I enzymes (mainly CYP) and Phase II enzymes (such as glutathione-S-transferases and UGT). Particularly, uridine glucuronyl transferase (UGT) represents one predominant enzyme in Phase II, which is involved in the metabolism pathways of 10% of the top 200 prescribed drugs. Additionally, UGT1A1, one UGT isoform, also plays a part in the glucuronidation of many endogenous products, such as bilirubin, estrogens, and flavonoids. Hence, inhibitory or inducing potentials of certain components might not only cause DDI side effects but also impair normal internal metabolism. Currently, UGT profiles are strongly recommended by regulatory authorities as part of in vitro DDI packages for IND submission. https://www.creative-biolabs.com/drug-discovery/therapeutics/ugt-investigation.htm .

Jerry Carter
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • CYP Investigation

    CYP Investigation

    Biomedical Sciences Shirley (New York) January 15, 2020 Check with publisher

    A drug-drug interaction occurs when two or more drugs are administrated simultaneously. Certain components of one drug may exert inducing or inhibiting effects on the metabolism of another drug by interfering the relevant enzymes, thus causing drug i...

  • Drug Distribution

    Drug Distribution

    Biomedical Sciences Shirley (New York) January 15, 2020 Check with publisher

    Proteins in blood can greatly influence the drug distribution in tissues. They influence a drug distributes from blood into tissues as well as from tissues to action sites. Only drugs that are unbound to components in the blood are free to diffuse ac...

  • Drug-Drug Interactions

    Drug-Drug Interactions

    Biomedical Sciences Shirley (New York) January 15, 2020 Check with publisher

    As there is increasing population taking multiple medications, adverse drug-drug interactions (DDI) has become a crucial issue. If a certain component of drug A changes the activity of enzymes or transporters involved in the metabolism of drug B, it ...